India fights ongoing leprosy spread despite progress

UPDATE - follow-up to Break the chain: On leprosy in India: India still faces ongoing leprosy transmission in many pockets, even though overall adult and child numbers and grade-2 disability rates fell over the last decade.

State Burdens and Goals

Disease reduction is uneven across the country, with Chhattisgarh, Jharkhand, Odisha, and Maharashtra carrying heavy shares of the national burden. The 2025-26 National Leprosy Elimination Programme report shows only 148 districts achieved interruption of transmission against a goal of 300. India met a major milestone by 2005 when national prevalence fell below 1 case per 10,000 people, leading the World Health Organization to declare public health elimination. The government then merged surveillance into the general health system and shortened multi-drug treatment registry times, which let transmission continue quietly while numbers looked low.

Screening and Action

Workers screened over 70 crore people in high-risk areas in 2025-26, finding 24,367 cases, while ASHA workers flagged nearly 40 lakh suspected cases and confirmed 48,027. Teams also gave single-dose rifampicin as prevention to 91.1% of the 16.9 lakh contacts identified. The state is now using digital tracking and considering the MIP vaccine to speed up pathogen clearance in infectious patients. Meanwhile, stigma causes late care-seeking that leads to nerve damage, and many doctors misdiagnose leprosy as a plain skin issue. The state must focus on stopping transmission rather than just chasing low prevalence goals, especially since 2025-26 incidence beat projections by 41%, child incidence overshot by 91.6%, and grade-2 disability rates exceeded estimates by 34%.

Context

Public health strategies often combine door-to-door screening with preventive medicine for close contacts to break disease chains in high-burden zones. Early detection remains critical for preventing long-term nerve damage and physical disability caused by untreated bacterial infections.